Brand-name GLP-1s may be covered for $50/month through the new Medicare Bridge Program, if you qualify
She has also received investigator-initiated grant support from Travere Therapeutics Inc, Bayer, the Doris Duke Charitable Foundation and Breakthrough T1D
Practical Strategies to Reduce Diarrhea Severity Dietary modification represents the most effective non-pharmacological approach to managing GLP-1-related diarrhea
While new therapies can address aspects of need relating to disease pathophysiology, they do not necessarily obviate barriers that are known to preclude optimal use of existing therapies [8]
This listing is not intended to provide clinical, injection, compounding, or consumer-use instructions
The $50/month Medicare program is a separate initiative specifically for Medicare patients